MARKETSACTIVE
24 mins ago
Innate Pharma S.A. (IPHA) Discusses IPH4502 Phase 1 Clinical Data and Development Outlook Transcript
SIGNALSMONITORMARKETS
What's happening
SignalsMonitor is following this as a markets story. Seeking Alpha is the outlet attached so far. The first report grouped here was at 18 Nov 2026, 23:12 UTC. The headline in use is “Innate Pharma S.A. (IPHA) Discusses IPH4502 Phase 1 Clinical Data and Development Outlook Transcript”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Innate Pharma S. A.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Seeking Alpha
Innate Pharma S.A. (IPHA) Discusses IPH4502 Phase 1 Clinical Data and Development Outlook Transcript
Reported by 1 outlet
- Seeking Alpha